JIMD Podcasts

Professor Bindoff and Professor Gorman, two luminaries of the world of mitochondrial medicine, speak with James Nurse about recent work in JIMD expanding knowledge on safe drug use in Primary Mitochondrial Disease. Professor Bindoff also explains a proposed classification for Polymerase Gamma disease including when to suspect this condition and how to investigate it. Safety of drug use in patients with a primary mitochondrial disease: An international Delphi‐based consensus Maaike C. De Vries et

Dr Emma Vardy, a Consultant Geriatrician from Salford, UK, explains the findings of a recent JIMD review looking at the impact of phenylketonuria in adulthood. With those who have benefitted from early treatment now approaching their fifth and sixth decades, PKU cannot just be seen as a disease of childhood and more work is needed to look into the long term impact of the condition. Phenylketonuria, co‐morbidity, and ageing: A review Emma R.L.C. Vardy, Anita MacDonald, Suzanne Ford, Denise L